Key result
Epstein-Barr virus infection can cause severe cardiovascular complications, including coronary artery lesions, myocarditis, and heart failure, with an estimated mortality rate of 15% to 50% among reported cases.
Why the study?
Cardiovascular involvement in Epstein-Barr virus infection can lead to severe outcomes, but reliable large-scale data and evidence-based guidance for its management are lacking.
This review synthesizes current knowledge on the pathogenesis, classification, treatment, and prognosis of cardiovascular complications associated with Epstein-Barr virus infection to enhance clinical recognition and management.
No takes yet. Share an insight, caveat, or question.
EBV cardiac complications warrant prompt evaluation to curb mortality; leaves open evidence-based management guidance.
Chen et al. (2023) conducted a review in Cardiovascular involvement in Epstein-Barr virus infection (n=54). Epstein-Barr virus infection was evaluated on Cardiovascular manifestations and prognosis. Epstein-Barr virus infection can cause severe cardiovascular complications, including coronary artery lesions, myocarditis, and heart failure, with an estimated mortality rate of 15% to 50% among reported cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: